Global and United States Bioburden Testing Market Report & Forecast 2022-2028

SKU ID : QYR-20800356 | Publishing Date : 22-Apr-2022 | No. of pages : 101

Detailed TOC of Global and United States Bioburden Testing Market Report & Forecast 2022-2028

1 Study Coverage
    1.1 Bioburden Testing Revenue in Bioburden Testing Business (2017-2022) & (US$ Million) Introduction
    1.2 Global Bioburden Testing Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Bioburden Testing Market Size for the Year 2017-2028
        1.2.2 Global Bioburden Testing Market Size for the Year 2017-2028
    1.3 Bioburden Testing Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.3.1 The Market Share of United States Bioburden Testing in Global, 2017 VS 2022 VS 2028
        1.3.2 The Growth Rate of Bioburden Testing Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.4 Bioburden Testing Market Dynamics
        1.4.1 Bioburden Testing Industry Trends
        1.4.2 Bioburden Testing Market Drivers
        1.4.3 Bioburden Testing Market Challenges
        1.4.4 Bioburden Testing Market Restraints
    1.5 Study Objectives
    1.6 Years Considered
2 Bioburden Testing by Type
    2.1 Bioburden Testing Market Segment by Type
        2.1.1 Instruments
        2.1.2 Consumables
    2.2 Global Bioburden Testing Market Size by Type (2017, 2022 & 2028)
    2.3 Global Bioburden Testing Market Size by Type (2017-2028)
    2.4 United States Bioburden Testing Market Size by Type (2017, 2022 & 2028)
    2.5 United States Bioburden Testing Market Size by Type (2017-2028)
3 Bioburden Testing by Application
    3.1 Bioburden Testing Market Segment by Application
        3.1.1 Pharmaceutical
        3.1.2 Biotechnology
    3.2 Global Bioburden Testing Market Size by Application (2017, 2022 & 2028)
    3.3 Global Bioburden Testing Market Size by Application (2017-2028)
    3.4 United States Bioburden Testing Market Size by Application (2017, 2022 & 2028)
    3.5 United States Bioburden Testing Market Size by Application (2017-2028)
4 Global Bioburden Testing Competitor Landscape by Company
    4.1 Global Bioburden Testing Market Size by Company
        4.1.1 Top Global Bioburden Testing Companies Ranked by Revenue (2021)
        4.1.2 Global Bioburden Testing Revenue by Player (2017-2022)
    4.2 Global Bioburden Testing Concentration Ratio (CR)
        4.2.1 Bioburden Testing Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Companies of Bioburden Testing in 2021
        4.2.3 Global Bioburden Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Bioburden Testing Headquarters, Revenue in Bioburden Testing Business (2017-2022) & (US$ Million) Type
        4.3.1 Global Bioburden Testing Headquarters and Area Served
        4.3.2 Global Bioburden Testing Companies Revenue in Bioburden Testing Business (2017-2022) & (US$ Million) Type
        4.3.3 Date of International Companies Enter into Bioburden Testing Market
    4.4 Companies Mergers & Acquisitions, Expansion Plans
    4.5 United States Bioburden Testing Market Size by Company
        4.5.1 Top Bioburden Testing Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Bioburden Testing Revenue by Players (2020, 2021 & 2022)
5 Global Bioburden Testing Market Size by Region
    5.1 Global Bioburden Testing Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Bioburden Testing Market Size by Region (2017-2028)
        5.2.1 Global Bioburden Testing Market Size by Region: 2017-2022
        5.2.2 Global Bioburden Testing Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Bioburden Testing Market Size YoY Growth 2017-2028
        6.1.2 North America Bioburden Testing Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Bioburden Testing Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Bioburden Testing Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe Bioburden Testing Market Size YoY Growth 2017-2028
        6.3.2 Europe Bioburden Testing Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Bioburden Testing Market Size YoY Growth 2017-2028
        6.4.2 Latin America Bioburden Testing Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Bioburden Testing Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Bioburden Testing Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 U.A.E
7 Company Profiles
    7.1 Charles River Laboratories International
        7.1.1 Charles River Laboratories International Company Details
        7.1.2 Charles River Laboratories International Business Overview
        7.1.3 Charles River Laboratories International Bioburden Testing Introduction
        7.1.4 Charles River Laboratories International Revenue in Bioburden Testing Business (2017-2022)
        7.1.5 Charles River Laboratories International Recent Development
    7.2 Sigma-Aldrich
        7.2.1 Sigma-Aldrich Company Details
        7.2.2 Sigma-Aldrich Business Overview
        7.2.3 Sigma-Aldrich Bioburden Testing Introduction
        7.2.4 Sigma-Aldrich Revenue in Bioburden Testing Business (2017-2022)
        7.2.5 Sigma-Aldrich Recent Development
    7.3 SGS
        7.3.1 SGS Company Details
        7.3.2 SGS Business Overview
        7.3.3 SGS Bioburden Testing Introduction
        7.3.4 SGS Revenue in Bioburden Testing Business (2017-2022)
        7.3.5 SGS Recent Development
    7.4 Wuxi Pharmatech (CAYMAN)
        7.4.1 Wuxi Pharmatech (CAYMAN) Company Details
        7.4.2 Wuxi Pharmatech (CAYMAN) Business Overview
        7.4.3 Wuxi Pharmatech (CAYMAN) Bioburden Testing Introduction
        7.4.4 Wuxi Pharmatech (CAYMAN) Revenue in Bioburden Testing Business (2017-2022)
        7.4.5 Wuxi Pharmatech (CAYMAN) Recent Development
    7.5 Merck
        7.5.1 Merck Company Details
        7.5.2 Merck Business Overview
        7.5.3 Merck Bioburden Testing Introduction
        7.5.4 Merck Revenue in Bioburden Testing Business (2017-2022)
        7.5.5 Merck Recent Development
    7.6 Becton Dickinson
        7.6.1 Becton Dickinson Company Details
        7.6.2 Becton Dickinson Business Overview
        7.6.3 Becton Dickinson Bioburden Testing Introduction
        7.6.4 Becton Dickinson Revenue in Bioburden Testing Business (2017-2022)
        7.6.5 Becton Dickinson Recent Development
    7.7 North American Science Associates Inc.
        7.7.1 North American Science Associates Inc. Company Details
        7.7.2 North American Science Associates Inc. Business Overview
        7.7.3 North American Science Associates Inc. Bioburden Testing Introduction
        7.7.4 North American Science Associates Inc. Revenue in Bioburden Testing Business (2017-2022)
        7.7.5 North American Science Associates Inc. Recent Development
    7.8 Nelson Laboratories
        7.8.1 Nelson Laboratories Company Details
        7.8.2 Nelson Laboratories Business Overview
        7.8.3 Nelson Laboratories Bioburden Testing Introduction
        7.8.4 Nelson Laboratories Revenue in Bioburden Testing Business (2017-2022)
        7.8.5 Nelson Laboratories Recent Development
    7.9 Pacific Biolabs
        7.9.1 Pacific Biolabs Company Details
        7.9.2 Pacific Biolabs Business Overview
        7.9.3 Pacific Biolabs Bioburden Testing Introduction
        7.9.4 Pacific Biolabs Revenue in Bioburden Testing Business (2017-2022)
        7.9.5 Pacific Biolabs Recent Development
    7.10 ATS Labs
        7.10.1 ATS Labs Company Details
        7.10.2 ATS Labs Business Overview
        7.10.3 ATS Labs Bioburden Testing Introduction
        7.10.4 ATS Labs Revenue in Bioburden Testing Business (2017-2022)
        7.10.5 ATS Labs Recent Development
8 Research Findings and Conclusion
9 Appendix
    9.1 Research Methodology
        9.1.1 Methodology/Research Approach
        9.1.2 Data Source
    9.2 Author Details
    9.3 Disclaimer

List of Figures, Tables and Charts Available in Global and United States Bioburden Testing Market Report & Forecast 2022-2028

List of Tables
    Table 1. Bioburden Testing Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Bioburden Testing Market Trends
    Table 3. Bioburden Testing Market Drivers
    Table 4. Bioburden Testing Market Challenges
    Table 5. Bioburden Testing Market Restraints
    Table 6. Global Bioburden Testing Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Bioburden Testing Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Bioburden Testing Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Bioburden Testing Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Bioburden Testing Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Bioburden Testing Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Bioburden Testing Revenue Share by Player, 2017-2022
    Table 13. Global Bioburden Testing Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Bioburden Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bioburden Testing as of 2021)
    Table 15. Top Players of Bioburden Testing in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Bioburden Testing Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Bioburden Testing Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Bioburden Testing Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Bioburden Testing Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Bioburden Testing Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Bioburden Testing Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Bioburden Testing Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Bioburden Testing Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Bioburden Testing Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Bioburden Testing Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Bioburden Testing Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Bioburden Testing Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Bioburden Testing Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. Charles River Laboratories International Company Details
    Table 31. Charles River Laboratories International Business Overview
    Table 32. Charles River Laboratories International Bioburden Testing Product
    Table 33. Charles River Laboratories International Revenue in Bioburden Testing Business (2017-2022) & (US$ Million)
    Table 34. Charles River Laboratories International Recent Development
    Table 35. Sigma-Aldrich Company Details
    Table 36. Sigma-Aldrich Business Overview
    Table 37. Sigma-Aldrich Bioburden Testing Product
    Table 38. Sigma-Aldrich Revenue in Bioburden Testing Business (2017-2022) & (US$ Million)
    Table 39. Sigma-Aldrich Recent Development
    Table 40. SGS Company Details
    Table 41. SGS Business Overview
    Table 42. SGS Bioburden Testing Product
    Table 43. SGS Revenue in Bioburden Testing Business (2017-2022) & (US$ Million)
    Table 44. SGS Recent Development
    Table 45. Wuxi Pharmatech (CAYMAN) Company Details
    Table 46. Wuxi Pharmatech (CAYMAN) Business Overview
    Table 47. Wuxi Pharmatech (CAYMAN) Bioburden Testing Product
    Table 48. Wuxi Pharmatech (CAYMAN) Revenue in Bioburden Testing Business (2017-2022) & (US$ Million)
    Table 49. Wuxi Pharmatech (CAYMAN) Recent Development
    Table 50. Merck Company Details
    Table 51. Merck Business Overview
    Table 52. Merck Bioburden Testing Product
    Table 53. Merck Revenue in Bioburden Testing Business (2017-2022) & (US$ Million)
    Table 54. Merck Recent Development
    Table 55. Becton Dickinson Company Details
    Table 56. Becton Dickinson Business Overview
    Table 57. Becton Dickinson Bioburden Testing Product
    Table 58. Becton Dickinson Revenue in Bioburden Testing Business (2017-2022) & (US$ Million)
    Table 59. Becton Dickinson Recent Development
    Table 60. North American Science Associates Inc. Company Details
    Table 61. North American Science Associates Inc. Business Overview
    Table 62. North American Science Associates Inc. Bioburden Testing Product
    Table 63. North American Science Associates Inc. Revenue in Bioburden Testing Business (2017-2022) & (US$ Million)
    Table 64. North American Science Associates Inc. Recent Development
    Table 65. Nelson Laboratories Company Details
    Table 66. Nelson Laboratories Business Overview
    Table 67. Nelson Laboratories Bioburden Testing Product
    Table 68. Nelson Laboratories Revenue in Bioburden Testing Business (2017-2022) & (US$ Million)
    Table 69. Nelson Laboratories Recent Development
    Table 70. Pacific Biolabs Company Details
    Table 71. Pacific Biolabs Business Overview
    Table 72. Pacific Biolabs Bioburden Testing Product
    Table 73. Pacific Biolabs Revenue in Bioburden Testing Business (2017-2022) & (US$ Million)
    Table 74. Pacific Biolabs Recent Development
    Table 75. ATS Labs Company Details
    Table 76. ATS Labs Business Overview
    Table 77. ATS Labs Bioburden Testing Product
    Table 78. ATS Labs Revenue in Bioburden Testing Business (2017-2022) & (US$ Million)
    Table 79. ATS Labs Recent Development
    Table 80. Research Programs/Design for This Report
    Table 81. Key Data Information from Secondary Sources
    Table 82. Key Data Information from Primary Sources
List of Figures
    Figure 1. Bioburden Testing Product Picture
    Figure 2. Global Bioburden Testing Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Bioburden Testing Market Size 2017-2028 (US$ Million)
    Figure 4. United States Bioburden Testing Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Bioburden Testing Market Size 2017-2028 (US$ Million)
    Figure 6. United States Bioburden Testing Market Share in Global 2017-2028
    Figure 7. Bioburden Testing Report Years Considered
    Figure 8. Product Picture of Instruments
    Figure 9. Product Picture of Consumables
    Figure 10. Global Bioburden Testing Market Share by Type in 2022 & 2028
    Figure 11. Global Bioburden Testing Market Size by Type (2017-2028) & (US$ Million)
    Figure 12. Global Bioburden Testing Market Share by Type (2017-2028)
    Figure 13. United States Bioburden Testing Market Share by Type in 2022 & 2028
    Figure 14. United States Bioburden Testing Market Size by Type (2017-2028) & (US$ Million)
    Figure 15. United States Bioburden Testing Market Share by Type (2017-2028)
    Figure 16. Product Picture of Pharmaceutical
    Figure 17. Product Picture of Biotechnology
    Figure 18. Global Bioburden Testing Market Share by Application in 2022 & 2028
    Figure 19. Global Bioburden Testing Market Size by Application (2017-2028) & (US$ Million)
    Figure 20. Global Bioburden Testing Market Share by Application (2017-2028)
    Figure 21. United States Bioburden Testing Market Share by Application in 2022 & 2028
    Figure 22. United States Bioburden Testing Market Size by Application (2017-2028) & (US$ Million)
    Figure 23. United States Bioburden Testing Market Share by Application (2017-2028)
    Figure 24. North America Bioburden Testing Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 25. U.S. Bioburden Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 26. Canada Bioburden Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 27. Europe Bioburden Testing Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 28. Germany Bioburden Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 29. France Bioburden Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 30. U.K. Bioburden Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 31. Italy Bioburden Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 32. Russia Bioburden Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 33. Asia-Pacific Bioburden Testing Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 34. China Bioburden Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 35. Japan Bioburden Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 36. South Korea Bioburden Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 37. India Bioburden Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. Australia Bioburden Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. Taiwan Bioburden Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. Indonesia Bioburden Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. Thailand Bioburden Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Malaysia Bioburden Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Philippines Bioburden Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Latin America Bioburden Testing Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 45. Mexico Bioburden Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Brazil Bioburden Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Argentina Bioburden Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Middle East & Africa Bioburden Testing Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 49. Turkey Bioburden Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Saudi Arabia Bioburden Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 51. U.A.E Bioburden Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Charles River Laboratories International Revenue Growth Rate in Bioburden Testing Business (2017-2022)
    Figure 53. Sigma-Aldrich Revenue Growth Rate in Bioburden Testing Business (2017-2022)
    Figure 54. SGS Revenue Growth Rate in Bioburden Testing Business (2017-2022)
    Figure 55. Wuxi Pharmatech (CAYMAN) Revenue Growth Rate in Bioburden Testing Business (2017-2022)
    Figure 56. Merck Revenue Growth Rate in Bioburden Testing Business (2017-2022)
    Figure 57. Becton Dickinson Revenue Growth Rate in Bioburden Testing Business (2017-2022)
    Figure 58. North American Science Associates Inc. Revenue Growth Rate in Bioburden Testing Business (2017-2022)
    Figure 59. Nelson Laboratories Revenue Growth Rate in Bioburden Testing Business (2017-2022)
    Figure 60. Pacific Biolabs Revenue Growth Rate in Bioburden Testing Business (2017-2022)
    Figure 61. ATS Labs Revenue Growth Rate in Bioburden Testing Business (2017-2022)
    Figure 62. Bottom-up and Top-down Approaches for This Report
    Figure 63. Data Triangulation
    Figure 64. Key Executives Interviewed

Keyplayers in Global and United States Bioburden Testing Market Report & Forecast 2022-2028

Charles River Laboratories International
Sigma-Aldrich
SGS
Wuxi Pharmatech (CAYMAN)
Merck
Becton Dickinson
North American Science Associates Inc.
Nelson Laboratories
Pacific Biolabs
ATS Labs